Diagnostics for hepatitis C: An urgent need for action

The Lancet Global Health

Volumn 3, Issue 4, 2015, Pages e195-195

  Denkinger, Claudia M ^a,b   Kessel, Mark ^a,c,d  

^a Malaria Fever Program   (Switzerland)

^b BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

^c Shearman and Sterling   (United Kingdom)

^d Symphony Capital LLC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALGORITHM; HEALTH CARE SYSTEM; HEPATITIS C; HUMAN IMMUNODEFICIENCY VIRUS; LETTER; MORTALITY; PERSONNEL MANAGEMENT; PRIORITY JOURNAL; PUBLIC HEALTH; SOCIOECONOMICS; TUBERCULOSIS; ECONOMICS; HEPACIVIRUS; HUMAN; ISOLATION AND PURIFICATION; POVERTY; SENSITIVITY AND SPECIFICITY; SEROLOGY; STANDARDS;

ALGORITHMS; HEPACIVIRUS; HEPATITIS C; HUMANS; POVERTY AREAS; SENSITIVITY AND SPECIFICITY; SEROLOGIC TESTS;

EID: 84925260633     PISSN: None     EISSN: 2214109X     Source Type: Journal    
DOI: 10.1016/S2214-109X(15)70092-6     Document Type: Letter

References (4)

1. Mohd Hanafiah K, Groeger J, Flaxman AD, Wiersma ST Global epidemiology of hepatitis C virus infection: new estimates of age-specific antibody to HCV seroprevalence. Hepatology 2013, 57:1333-1342.
2. Kamal-Yanni M Hepatitis C drug affordability. Lancet Glob Health 2015, 3:e73-e74.
3. Hepatitis C medicines and diagnostics in the context of HIV/HCV co-infection: a scoping report 2013, UNITAID, UNITAID, Geneva.
4. Smith BD, Drobeniuc J, Jewett A, et al. Evaluation of three rapid screening assays for detection of antibodies to hepatitis C virus. J Infect Dis 2011, 204:825-831.